Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Abstract Unlike conventional Coronavirus 2019 (COVID-19) vaccines, intranasal vaccines
display a superior advantage because the nasal mucosa is often the initial site of infection …
display a superior advantage because the nasal mucosa is often the initial site of infection …
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
J Li, Y Zhou, J Ma, Q Zhang, J Shao, S Liang… - … and Targeted Therapy, 2023 - nature.com
There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …
A year of Covid-19: A long road to recovery and acceleration of Indonesia's development
M Muhyiddin, H Nugroho - … Pembangunan: The Indonesian …, 2021 - journal.bappenas.go.id
Abstract 2020 is the year of Covid-19, Indonesia feels the enormity of this pandemic in
various aspects of development. The Indonesian economy during the year slowed down to …
various aspects of development. The Indonesian economy during the year slowed down to …
A global picture: therapeutic perspectives for COVID-19
VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
Microfluidics-based point-of-care testing (POCT) devices in dealing with waves of COVID-19 pandemic: the emerging solution
Recent advances in microfluidics-based point-of-care testing (POCT) technology such as
paper, array, and beads have shown promising results for diagnosing various infectious …
paper, array, and beads have shown promising results for diagnosing various infectious …
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
Pancreatic cancer (PC) is a fatal disease that has a poor 5-year survival rate. The poor
prognosis can be attributed to both troublesome detections at the initial stage, which makes …
prognosis can be attributed to both troublesome detections at the initial stage, which makes …
Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly …
H Ghobadi, J Mohammadshahi, N Javaheri… - Frontiers in …, 2022 - frontiersin.org
Background Systemic inflammation indices, including neutrophil/lymphocyte ratio (NLR),
monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), derived …
monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), derived …
Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study
H Zhang, Y Wu, Y He, X Liu, M Liu, Y Tang, X Li… - Frontiers in …, 2022 - frontiersin.org
Objective: To study the differences in clinical characteristics, risk factors, and complications
across age-groups among the inpatients with the coronavirus disease 2019 (COVID-19) …
across age-groups among the inpatients with the coronavirus disease 2019 (COVID-19) …
Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity
K Gupta, G Kaur, T Pathak, I Banerjee - Gene, 2022 - Elsevier
The COVID-19 pandemic has spawned global health crisis of unprecedented magnitude,
claiming millions of lives and pushing healthcare systems in many countries to the brink …
claiming millions of lives and pushing healthcare systems in many countries to the brink …
[HTML][HTML] Remdesivir efficacy in COVID-19 treatment: a randomized controlled trial
S Abd-Elsalam, M Salama, S Soliman… - The American Journal …, 2022 - ncbi.nlm.nih.gov
To date, no antiviral therapy has shown proven clinical effectiveness in treating patients with
COVID-19. We assessed the efficacy of remdesivir in hospitalized Egyptian patients with …
COVID-19. We assessed the efficacy of remdesivir in hospitalized Egyptian patients with …